 | • レポートコード：MRC2-11QY04131 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は過活動膀胱治療薬のグローバル市場について調査・分析したレポートです。種類別（抗コリン作用薬、ミラベグロン、ボトックス）市場規模、用途別（特発性過活動膀胱、神経因性過活動膀胱）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別過活動膀胱治療薬の競争状況、市場シェア ・世界の過活動膀胱治療薬市場：種類別市場規模 2015年-2020年（抗コリン作用薬、ミラベグロン、ボトックス） ・世界の過活動膀胱治療薬市場：種類別市場規模予測 2021年-2026年（抗コリン作用薬、ミラベグロン、ボトックス） ・世界の過活動膀胱治療薬市場：用途別市場規模 2015年-2020年（特発性過活動膀胱、神経因性過活動膀胱） ・世界の過活動膀胱治療薬市場：用途別市場規模予測 2021年-2026年（特発性過活動膀胱、神経因性過活動膀胱） ・北米の過活動膀胱治療薬市場分析：米国、カナダ ・ヨーロッパの過活動膀胱治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの過活動膀胱治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の過活動膀胱治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの過活動膀胱治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma、Allergan、Pfizer、Johnson & Johnson、Teva (Activas) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2017, North America accounts for 49.59%.
Market Analysis and Insights: Global Overactive Bladder Therapeutics Market
The global Overactive Bladder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Overactive Bladder Therapeutics Scope and Market Size
Overactive Bladder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Overactive Bladder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astellas Pharma
Allergan
Pfizer
Johnson & Johnson
Teva (Activas)
…
Market segment by Type, the product can be split into
Anticholinergics
Mirabegron
Botox
Market segment by Application, split into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Overactive Bladder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Overactive Bladder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticholinergics
1.4.3 Mirabegron
1.4.4 Botox
1.5 Market by Application
1.5.1 Global Overactive Bladder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Idiopathic Overactive Bladder
1.5.3 Neurogenic Overactive Bladder
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Overactive Bladder Therapeutics Market Perspective (2015-2026)
2.2 Global Overactive Bladder Therapeutics Growth Trends by Regions
2.2.1 Overactive Bladder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Overactive Bladder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Overactive Bladder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Overactive Bladder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Overactive Bladder Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Overactive Bladder Therapeutics Players by Market Size
3.1.1 Global Top Overactive Bladder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Overactive Bladder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Overactive Bladder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Overactive Bladder Therapeutics Market Concentration Ratio
3.2.1 Global Overactive Bladder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Overactive Bladder Therapeutics Revenue in 2019
3.3 Overactive Bladder Therapeutics Key Players Head office and Area Served
3.4 Key Players Overactive Bladder Therapeutics Product Solution and Service
3.5 Date of Enter into Overactive Bladder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Overactive Bladder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Overactive Bladder Therapeutics Market Size by Application (2015-2020)
5.2 Global Overactive Bladder Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Overactive Bladder Therapeutics Market Size (2015-2020)
6.2 Overactive Bladder Therapeutics Key Players in North America (2019-2020)
6.3 North America Overactive Bladder Therapeutics Market Size by Type (2015-2020)
6.4 North America Overactive Bladder Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Overactive Bladder Therapeutics Market Size (2015-2020)
7.2 Overactive Bladder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Overactive Bladder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Overactive Bladder Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Overactive Bladder Therapeutics Market Size (2015-2020)
8.2 Overactive Bladder Therapeutics Key Players in China (2019-2020)
8.3 China Overactive Bladder Therapeutics Market Size by Type (2015-2020)
8.4 China Overactive Bladder Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Overactive Bladder Therapeutics Market Size (2015-2020)
9.2 Overactive Bladder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Overactive Bladder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Overactive Bladder Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Overactive Bladder Therapeutics Market Size (2015-2020)
10.2 Overactive Bladder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Overactive Bladder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Overactive Bladder Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Overactive Bladder Therapeutics Market Size (2015-2020)
11.2 Overactive Bladder Therapeutics Key Players in India (2019-2020)
11.3 India Overactive Bladder Therapeutics Market Size by Type (2015-2020)
11.4 India Overactive Bladder Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Overactive Bladder Therapeutics Market Size (2015-2020)
12.2 Overactive Bladder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Overactive Bladder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Overactive Bladder Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Details
13.1.2 Astellas Pharma Business Overview
13.1.3 Astellas Pharma Overactive Bladder Therapeutics Introduction
13.1.4 Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2015-2020))
13.1.5 Astellas Pharma Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Overactive Bladder Therapeutics Introduction
13.2.4 Allergan Revenue in Overactive Bladder Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Overactive Bladder Therapeutics Introduction
13.3.4 Pfizer Revenue in Overactive Bladder Therapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Overactive Bladder Therapeutics Introduction
13.4.4 Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Teva (Activas)
13.5.1 Teva (Activas) Company Details
13.5.2 Teva (Activas) Business Overview
13.5.3 Teva (Activas) Overactive Bladder Therapeutics Introduction
13.5.4 Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2015-2020)
13.5.5 Teva (Activas) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Overactive Bladder Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Overactive Bladder Therapeutics Revenue
Table 3. Ranking of Global Top Overactive Bladder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Overactive Bladder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticholinergics
Table 6. Key Players of Mirabegron
Table 7. Key Players of Botox
Table 8. Global Overactive Bladder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Overactive Bladder Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Overactive Bladder Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Overactive Bladder Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Overactive Bladder Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Overactive Bladder Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Overactive Bladder Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Overactive Bladder Therapeutics Players
Table 19. Global Overactive Bladder Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Overactive Bladder Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Overactive Bladder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Therapeutics as of 2019)
Table 22. Global Overactive Bladder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Overactive Bladder Therapeutics Product Solution and Service
Table 25. Date of Enter into Overactive Bladder Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Overactive Bladder Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Overactive Bladder Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Overactive Bladder Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Overactive Bladder Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 35. North America Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 37. North America Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 41. Europe Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 47. China Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 49. China Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 53. Japan Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 65. India Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 67. India Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Overactive Bladder Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Overactive Bladder Therapeutics Market Share (2019-2020)
Table 71. Central & South America Overactive Bladder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Overactive Bladder Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Overactive Bladder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Overactive Bladder Therapeutics Market Share by Application (2015-2020)
Table 75. Astellas Pharma Company Details
Table 76. Astellas Pharma Business Overview
Table 77. Astellas Pharma Product
Table 78. Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2015-2020) (Million US$)
Table 79. Astellas Pharma Recent Development
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Product
Table 83. Allergan Revenue in Overactive Bladder Therapeutics Business (2015-2020) (Million US$)
Table 84. Allergan Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Overactive Bladder Therapeutics Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2015-2020) (Million US$)
Table 94. Johnson & Johnson Recent Development
Table 95. Teva (Activas) Company Details
Table 96. Teva (Activas) Business Overview
Table 97. Teva (Activas) Product
Table 98. Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2015-2020) (Million US$)
Table 99. Teva (Activas) Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Overactive Bladder Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anticholinergics Features
Figure 3. Mirabegron Features
Figure 4. Botox Features
Figure 5. Global Overactive Bladder Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Idiopathic Overactive Bladder Case Studies
Figure 7. Neurogenic Overactive Bladder Case Studies
Figure 8. Overactive Bladder Therapeutics Report Years Considered
Figure 9. Global Overactive Bladder Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Overactive Bladder Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Overactive Bladder Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Overactive Bladder Therapeutics Market Share by Players in 2019
Figure 14. Global Top Overactive Bladder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Overactive Bladder Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Overactive Bladder Therapeutics Revenue in 2019
Figure 16. North America Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Overactive Bladder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
過活動膀胱（OAB）治療薬の世界市場（～2026年） Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overac…- 膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 膀胱がん治療薬の世界市場（～2026年） Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles. The increase in prevalence of bladder cancer, advanced health care services, technological advancements, dr…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 特発性頭蓋内圧亢進症治療薬の世界市場（～2026年） A drug used to treat idiopathic intracranial hypertension. Market Analysis and Insights: Global Idiopathic Intracranial Hypertension Therapeutics Market The global Idiopathic Intracranial Hypertension Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…